Article Details
Retrieved on: 2021-08-01 15:48:16
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
However, the concern with utilizing a monoclonal antibody in this setting is that it will not cross the blood brain barrier, she says. As such lazertinib ...
Article found on: www.onclive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here